GlassScriptPhysician profile
Miri Chang
NPI 1851610158
$2,906.74
in general payments reported to CMS, 2019-2025
20 companies · $895 in 2025
The $895 reported for 2025 was more than what 85% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $862 · 2022: $211 · 2023: $400 · 2024: $539 · 2025: $895.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,834.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,834.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $883.77 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $365.74 | 2023-2025 | Farxiga |
| Akebia Therapeutics INC | $218.94 | 2024-2025 | Vafseo, Auryxia |
| Ardelyx, INC. | $171.54 | 2023-2025 | Ibsrela |
| Amgen INC. | $150.10 | 2022-2025 | Krystexxa |
| E.R. Squibb & Sons, L.L.C. | $125.38 | 2021 | |
| Alkermes, INC. | $125.00 | 2021 | |
| Horizon Therapeutics Plc | $124.97 | 2023 | Krystexxa |
| Abbott Laboratories | $113.03 | 2021-2022 | |
| Lilly USA, LLC | $84.41 | 2021-2025 | Mounjaro, Zepbound |
| Sanofi-Aventis U.S. LLC | $81.17 | 2021-2022 | |
| Fresenius USA Marketing, INC. | $75.42 | 2024-2025 | Velphoro, Velphoro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $72.07 | 2021-2024 | Jardiance |
| Pfizer INC. | $70.01 | 2024-2025 | |
| Xeris Pharmaceuticals, INC. | $60.77 | 2021-2024 | Gvoke Hypopen |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $53.55 | 2021-2025 | Dexcom G6 Transmitter |
| Boston Scientific Corporation | $46.99 | 2023 | Wavewriter Alpha Prime 16 |
| Bayer Healthcare Pharmaceuticals INC. | $42.52 | 2023-2025 | |
| Exact Sciences Corporation | $27.95 | 2025 | Cologuard Collection Kit |
| Opko Pharmaceuticals, LLC | $13.41 | 2024 | Rayaldee |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Miri Chang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.